scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, has announced the closing of a senior secured term loan and a royalty investment together totaling up to US$125 million from funds managed by Perceptive Advisors, a leading life-sciences focused investor.
Latham & Watkins LLP represented scPharmaceuticals in the transaction with a team led by partners Haim Zaltzman and Dan Van Fleet, with associates Erin Cusenbary, Tony Noh, and Ian Drazen. Advice was also provided on tax matters by partner Kirt Switzer, with associate Gregory Conyers; on healthcare and life sciences matters by partner Jekkie Kim, with associates Mizuna Sekine and Patrick Chew; on FDA regulatory matters by partner Betty Pang and counsel Chad Jennings; on ERISA matters by partner Josh Friedman; and on corporate matters by partner Wesley Holmes.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
